# Immune Durability After VSV-EBOV Vaccination

> **NCT02933931** · — · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 95 (actual)

## Conditions studied

- Immune Response
- Vaccination
- Durability

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02933931
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933931, "Immune Durability After VSV-EBOV Vaccination". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02933931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*